References
- Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004;184:386–92.
- Agency TSSI. Social Insurance Report—What are the costs for different diseases in Swedish sickness insurance? 2011.
- Hensing G, Wahlstrom R. Swedish Council on Technology Assessment in Health Care (SBU). Chapter 7. Sickness absence and psychiatric disorders. Scand J Public Health Suppl 2004;63:152–80.
- Bratberg E, Gjesdal S, Maeland JG. Sickness absence with psychiatric diagnoses: Individual and contextual predictors of permanent disability. Health Place 2009;15:308–14.
- Vaez M, Rylander G, Nygren A, Asberg M, Alexanderson K. Sickness absence and disability pension in a cohort of employees initially on long-term sick leave due to psychiatric disorders in Sweden. Soc Psychiatry Psychiatr Epidemiol 2007;42:381–8.
- Holma IA, Holma KM, Melartin TK, Rytsala HJ, Isometsa ET. A 5-year prospective study of predictors for disability pension among patients with major depressive disorder. Acta Psychiatr Scand 2012;125:325–34.
- Cornelius LR, van der Klink JJ, Groothoff JW, Brouwer S. Prognostic factors of long term disability due to mental disorders: A systematic review. J Occup Rehabil 2011;21:259–74.
- Bengtsson F, Henriksson F, Håkansson I, Karlsson I, von Knorring AL, Kimbré S, et al. Behandling av depressionsjukdomar En systematisk litteraturöversikt. Stockholm: SBU Statens beredning for medicinsk utvärdering; 2004.
- Greener MJ, Guest JF. Do antidepressants reduce the burden imposed by depression on employers?CNS Drugs 2005;19: 253–64.
- Petrides G, Fink M, Husain MM, Knapp RG, Rush AJ, Mueller M, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: A report from CORE. J Ect 2001;17:244–53.
- ;American Psychiatric Association. Committee on Electroconvulsive TherapyWeiner RD. The practice of electroconvulsive therapy: Recommendations for treatment, training, and privileging: A task force report of the American Psychiatric Association, 2nd edition. Washington, D.C.: APA; 2001.
- Agency TSSI. Social Insurance Report—Uppföljning av försörjningskällor och sysselsättning efter avslutad period med sjukpenning; 2009.
- Guy W. ECDEU assessment manual for psychopharmacology. In: Rockville, MD: National Institute of Health, Psychopharmacology Research Branch; 1976. p. 217–22.
- Mintz J, Mintz LI, Arruda MJ, Hwang SS. Treatments of depression and the functional capacity to work. Arch Gen Psychiatry 1992;49:761–8.
- Godard J, Baruch P, Grondin S, Lafleur MF. Psychosocial and neurocognitive functioning in unipolar and bipolar depression: A 12-month prospective study. Psychiatry Res 2012;196:145–53.
- Gjesdal S, Bratberg E. Diagnosis and duration of sickness absence as predictors for disability pension: Results from a three-year, multi-register based and prospective study. Scand J Public Health 2003;31:246–54.
- Pettinati HM, Stephens SM, Willis KM, Robin SE. Evidence for less improvement in depression in patients taking benzodiazepines during unilateral ECT. Am J Psychiatry 1990;147:1029–35.
- Nordenskjold A, von Knorring L, Engstrom I. Predictors of time to relapse/recurrence after electroconvulsive therapy in patients with major depressive disorder: A population-based cohort study. Depress Res Treat 2011;2011:470985.
- Wu X, Castren E. Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biol Psychiatry 2009;66:5–8.
- Hickie I, Mason C, Parker G, Brodaty H. Prediction of ECT response: Validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry 1996;169:68–74.
- Nordenskjold A, von Knorring L, Engstrom I. Predictors of the short-term responder rate of electroconvulsive therapy in depressive disorders—A population based study. BMC Psychiatry 2012;12:115.
- Birkenhager TK, Renes JW, Pluijms EM. One-year follow-up after successful ECT: A naturalistic study in depressed inpatients. J Clin Psychiatry 2004;65:87–91.
- Sackeim HA, Haskett RF, Mulsant BH, Thase ME, Mann JJ, Pettinati HM, et al. Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: A randomized controlled trial. JAMA 2001;285:1299–307.